tesamorelin or retatrutide and combined (why this works so well) Comment “LEAN” for the research playbook People are stressing out about how delayed gastric emptying will mute the GH pulse from Tesamorelin… That Tonight's peptide stack 🤍 Retatrutide

Stacking it with another GLP-1 agonist like semaglutide would be redundant and increase side effects without proportional benefit

Should those oral drugs succeed in Phase 3 trials, they would likely come to the market around 2029, three years behind Lilly, which introduced its small molecule pill Foundayo earlier this year (the Wegovy pill is an oral peptide)

Sources Eli Lilly press release: TRIUMPH-1 Phase 3 topline results

Methods Enzymol

Clinical research has mainly focused on adults who may benefit from additional support with weight management, particularly those with obesity, a higher BMI or health conditions linked to excess weight

The commonest side effects of GLP-1 agonists include nausea, abdominal pain, constipation, diarrhea, and vomiting